Article
Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation.
Laboratory of Cellular and Molecular Biochemistry, School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.
Journal of Biological Chemistry (impact factor:
4.77).
10/2010;
285(51):40294-302.
DOI:10.1074/jbc.M110.126821
pp.40294-302
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Evolution of the Ferric Reductase Domain (FRD) Superfamily: Modularity, Functional Diversification, and Signature Motifs.
[show abstract] [hide abstract]
ABSTRACT: A heme-containing transmembrane ferric reductase domain (FRD) is found in bacterial and eukaryotic protein families, including ferric reductases (FRE), and NADPH oxidases (NOX). The aim of this study was to understand the phylogeny of the FRD superfamily. Bacteria contain FRD proteins consisting only of the ferric reductase domain, such as YedZ and short bFRE proteins. Full length FRE and NOX enzymes are mostly found in eukaryotic cells and all possess a dehydrogenase domain, allowing them to catalyze electron transfer from cytosolic NADPH to extracellular metal ions (FRE) or oxygen (NOX). Metazoa possess YedZ-related STEAP proteins, possibly derived from bacteria through horizontal gene transfer. Phylogenetic analyses suggests that FRE enzymes appeared early in evolution, followed by a transition towards EF-hand containing NOX enzymes (NOX5- and DUOX-like). An ancestral gene of the NOX(1-4) family probably lost the EF-hands and new regulatory mechanisms of increasing complexity evolved in this clade. Two signature motifs were identified: NOX enzymes are distinguished from FRE enzymes through a four amino acid motif spanning from transmembrane domain 3 (TM3) to TM4, and YedZ/STEAP proteins are identified by the replacement of the first canonical heme-spanning histidine by a highly conserved arginine. The FRD superfamily most likely originated in bacteria.PLoS ONE 01/2013; 8(3):e58126. · 4.09 Impact Factor -
Article: Never-ageing cellular senescence.
[show abstract] [hide abstract]
ABSTRACT: Cellular senescence was historically discovered as a form of cellular ageing of in vitro cultured cells. It has been under the spotlight following the evidence of oncogene-induced senescence in vivo and its role as a potent tumour suppressor mechanism. Presently, a PubMed search using keywords 'cellular senescence and cancer' reveals 8398 number of references (by April 2011) showing that while our knowledge of senescence keeps expanding, the complexity of the phenomenon keeps us - researchers in the field of cancer biology--fascinated and busy. In this short review, we summarise the many cellular pathways leading to cellular senescence and we discuss the latest experimental evidence and the questions emerging in the field.European journal of cancer (Oxford, England: 1990) 05/2011; 47(11):1616-22. · 4.12 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
Akt phosphorylation
ATDC5 cells
depletion
differentiation process
intracellular level
mouse embryos
NADPH oxidases
Nox1
Nox2
Nox4 expression
possible contribution
primary chondrocytes
primary mouse chondrocytes
proliferating chondrocytes
reactive oxygen species
role ROS
ROS generation
ROS scavenger N-acetylcysteine
signal transduction
subsequent activation